Lv1
54 积分 2025-03-05 加入
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
1天前
已完结
Divergent destinies of polymorphism
1个月前
已完结
The rise of ‘nightmare bacteria’: antimicrobial resistance in five charts
1个月前
已完结
Combining antibiotics to tackle antimicrobial resistance
2个月前
已完结
B-cell non-Hodgkin lymphomas
3个月前
已完结
Impact of Time-to-relapse on Biology, Evolutionary Dynamics, and Chemosensitivity in Diffuse Large B-cell Lymphoma
3个月前
已关闭
Diffuse Large B-Cell Lymphoma
3个月前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
3个月前
已完结
Chronic lymphocytic leukaemia
3个月前
已完结
Chronic lymphocytic leukaemia
3个月前
已完结
皖公网安备34019202002308
